Progress toward a group B streptococcal vaccine

Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of severe invasive disease in neonate, elderly, and immunocompromised patients worldwide. Despite recent advances in the diagnosis and intrapartum antibiotic prophylaxis (IAP) of GBS infections, it remains one of the most commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Joon Young, Lim, Jae Hyang, Lim, Sangyong, Yong, Zhi, Seo, Ho Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314413/
https://www.ncbi.nlm.nih.gov/pubmed/29995578
http://dx.doi.org/10.1080/21645515.2018.1493326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314413/
https://www.ncbi.nlm.nih.gov/pubmed/29995578
http://dx.doi.org/10.1080/21645515.2018.1493326

Ejemplares similares